National Financial Statements From 2010 to 2024
| NRC Stock | USD 18.75 0.08 0.42% |
Check National Research financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among National Research's main balance sheet or income statement drivers, such as , as well as many indicators such as . National financial statements analysis is a perfect complement when working with National Research Valuation or Volatility modules.
National |
National Research Corp Company Return On Equity Analysis
National Research's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current National Research Return On Equity | 0.59 |
Most of National Research's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, National Research Corp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
| Competition |
Based on the latest financial disclosure, National Research Corp has a Return On Equity of 0.5856. This is 102.44% lower than that of the Health Care Providers & Services sector and significantly higher than that of the Health Care industry. The return on equity for all United States stocks is notably lower than that of the firm.
National Research Corp Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining National Research's current stock value. Our valuation model uses many indicators to compare National Research value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across National Research competition to find correlations between indicators driving National Research's intrinsic value. More Info.National Research Corp is considered to be number one stock in return on equity category among its peers. It also is considered to be number one stock in return on asset category among its peers reporting about 0.32 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for National Research Corp is roughly 3.16 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the National Research's earnings, one of the primary drivers of an investment's value.About National Research Financial Statements
National Research stakeholders use historical fundamental indicators, such as National Research's revenue or net income, to determine how well the company is positioned to perform in the future. Although National Research investors may analyze each financial statement separately, they are all interrelated. For example, changes in National Research's assets and liabilities are reflected in the revenues and expenses on National Research's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in National Research Corp. Please read more on our technical analysis and fundamental analysis pages.
National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience in the United States and Canada. National Research Corporation was founded in 1981 and is headquartered in Lincoln, Nebraska. National Research operates under Health Information Services classification in the United States and is traded on NASDAQ Exchange. It employs 511 people.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether National Research Corp offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of National Research's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of National Research Corp Stock. Outlined below are crucial reports that will aid in making a well-informed decision on National Research Corp Stock:Check out the analysis of National Research Correlation against competitors. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Is Business Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of National Research. If investors know National will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about National Research listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of National Research Corp is measured differently than its book value, which is the value of National that is recorded on the company's balance sheet. Investors also form their own opinion of National Research's value that differs from its market value or its book value, called intrinsic value, which is National Research's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because National Research's market value can be influenced by many factors that don't directly affect National Research's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between National Research's value and its price as these two are different measures arrived at by different means. Investors typically determine if National Research is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, National Research's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.